Single-Blind Randomized Clinical Trial of Concomitant Hip Arthroscopy During Periacetabular Osteotomy for Hip Dysplasia

What this Trial Is About

Researchers are evaluating the outcomes of patients with hip dysplasia who undergo periacetabular osteotomy (PAO) surgery, comparing those who receive additional hip arthroscopy at the time of PAO with those who have PAO alone. The study aims to determine if adding intraarticular work during PAO improves pain and function, especially for patients with certain signs of joint damage or mechanical symptoms. This is a single-blind randomized clinical trial sponsored by Mayo Clinic. Participants are divided into two groups: one receives the standard PAO procedure on the day of surgery, and the other undergoes hip arthroscopy followed by PAO on the same day. Hip arthroscopy allows the surgeon to inspect and treat labral and cartilage issues, as well as correct abnormalities in the femoral head junction. The study focuses on patients aged 15 to 55 who have minimal or no arthritis and meet specific imaging criteria. During the study, researchers will assess participants using several outcome measures at one year after surgery, including scores for hip disability, osteoarthritis symptoms, activity levels, and functional ability. Participants will undergo standard preoperative imaging such as MRI arthrograms. The trial monitors pain, function, and activity outcomes to compare the benefits of adding hip arthroscopy to PAO surgery. The total participation and follow-up duration include assessments at one year post-operation.

Clinical Trial of Concomitant Hip Arthroscopy During PAO